Swedbank
CHRS icon

Swedbank’s Coherus Oncology CHRS Stock Holding History

Swedbank’s Portfolio CHRS Stock Details CHRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-539,803
Closed -$6.97M – 750
2022
Q1 		$6.97M Sell
539,803
-310,197
-36% -$3.94M 0.01% 497
2021
Q4 		$14.2M Hold
850,000
– – 0.02% 408
2021
Q3 		$13.7M Hold
850,000
– – 0.03% 411
2021
Q2 		$11.8M Hold
850,000
– – 0.02% 452
2021
Q1 		$12.4M Buy
+850,000
New +$14.4M 0.03% 419

Other funds holding CHRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Swedbank's CHRS Position: Q2 2022 in Review

Swedbank sold out of Coherus Oncology (CHRS) in Q2 2022, closing a stake of 539,803 shares — an estimated $6.97M sold.

Swedbank first reported a position in CHRS in Q1 2021 and held it in 5 quarters. The position peaked at $14.2M in Q4 2021. 176 funds tracked by Wall St. Rank hold CHRS as of Q2 2022.

  • Swedbank reported no remaining Coherus Oncology position as of Q2 2022 after selling out during the quarter.
  • Swedbank sold 539,803 Coherus Oncology shares in Q2 2022, an estimated $6.97M.
  • Swedbank first reported a position in Coherus Oncology in Q1 2021 and held it in 5 quarters.
  • Swedbank's Coherus Oncology position peaked at $14.2M in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2022.

Based on Swedbank's 13F filing for Q2 2022, filed 6 Dec 2024.